Yoco para stimulant
Paullinia yoco — 7 estudios científicos revisados
Preliminary¿Sirve Yoco para stimulant?
La investigación científica ha explorado el potencial de Yoco (Paullinia yoco) en relación con stimulant. Se han identificado 7 estudios relevantes que examinan esta relación.
Compuestos activos involucrados: Alcaloides, Cafeína, Flavonoides, Glucósido, Glucósidos, Saponinas, Terpenos, Adenosina, Fenoles, Polifenoles, Xantina
Evidencia Científica
Los siguientes estudios han investigado la relación entre Yoco y stimulant:
Amazonian ethnobotany and the search for new drugs.
Tropical rain forests offer enormous prospects for the discovery of new drugs for use in Western medicine. The Amazon supports 80,000 species of higher plants and a diverse Indian population. Focusing attention on those plants used as medicines by indigenous peoples is the most efficient way of identifying the plants that contain bioactive compounds. There is an urgent need for more ethnobotanists and ethnopharmacologists to be trained to document as much information as possible before it and the plants are lost through destruction of the rain forest and acculturation of the indigenous peoples
PubMed: 7736849Purine alkaloids in Paullinia.
Among the few purine alkaloid-containing genera consumed as stimulants, Paullinia is the least investigated with respect to both chemotaxonomy and within-the-plant allocation of caffeine and its allies. Since purine alkaloids (PuA) have been proved to be valuable marker compounds in chemotaxonomy, 34 species of Paullinia and related genera were screened for them, but only one, P. pachycarpa, was positive in addition to the already known P. cupana and P. yoco.
PubMed: 13679096Effects of Guarana and Green Tea Consumption on Students' Intellectual Performances.
BACKGROUND: guarana and green tea are known as compounds that may improve cognitive performance due to their high content of caffeine and other neurostimulants, such as theobromine in the case of guarana and ECGC (apigalocatechin-3-galate) in that of green tea. METHODS: this study investigates the effects of RESULTS AND DISCUSSION: the results showed that both guarana and green tea fostered significant improvements in cognitive performance. However, more people felt the effect of guarana than the effect of green tea. The study found a strong correlation between cognitive effects and guarana a
PubMed: 40290036Cancer-related fatigue: a review.
Cancer-related fatigue is the most prevalent cancer symptom, reported in 50%-90% of patients and severely impacts quality of life and functional capacity. The condition remains underreported and often goes untreated. Guidelines suggest screening for fatigue at the initial visit, when the diagnosis of advanced disease is made, and at each chemotherapy session, as well as the identification of treatable contributing factors such as anemia, hypothyroidism, depression and sleep disorders. Brief assessment tools such as the Brief Fatigue Inventory or the Visual Analog Scale may be appropriate in th
PubMed: 21537710Clinical toxicology study of an herbal medicinal extract of Paullinia cupana, Trichilia catigua, Ptychopetalum olacoides and Zingiber officinale (Catuama) in healthy volunteers.
In Brazil, a herbal medicinal extract named Catuama containing a mixture of Paullinia cupana (guarana; Sapindaceae), Trichilia catigua (catuaba; Meliaceae), Ptychopetalum olacoides (muirapuama; Olacaceae) and Zingiber officinale (ginger; Zingiberaceae) is used as a body stimulant, energetic, tonic and aphrodisiac. The present study investigated the chronic administration of 25 mL Catuama twice a day during 28 days for any toxic effect on healthy human volunteers of both sexes. No severe adverse reactions or haematological and biochemical changes were reported.
PubMed: 15798997Seguridad y Precauciones
La seguridad del consumo de Paullinia yoco carece de validación clínica exhaustiva en humanos, lo que obliga a una postura de extrema cautela ante su uso. Debido a su composición rica en alcaloides y cafeína, su uso está estrictamente desaconsejado en mujeres embarazadas y en periodo de lactancia. La cafeína es capaz de atravesar la barrera placentaria, lo que conlleva el riesgo de inducir taquicardia fetal y posibles alteraciones en el desarrollo del sistema nervioso central del feto; en la lactancia, los compuestos pueden pasar a la leche materna, afectando el patrón de sueño y la estabilidad metabólica del lactante. En la población infantil menor de 12 años, la introducción de estos estimulantes es altamente riesgosa, ya que su sistema nervioso aún se encuentra en una fase crítica de maduración, lo que puede derivar en cuadros de irritabilidad extrema, insomnio severo y desequilibrios en la regulación del ritmo cardíaco. En cuanto a las interacciones medicamentosas, el yoco presenta peligros específicos: con la warfarina, los flavonoides y saponinas presentes podrían interferir con las cascadas de coagulación, aumentando el riesgo de hemorragias; con la metformina, los alcaloides estimulantes pueden actuar como antagonistas de la sensibilidad a la insulina, dificultando el control glucémico; y con los fármacos antihipertensivos, la cafeína ejerce un efecto farmacodinámico opuesto, elevando la presión arterial y la frecuencia cardíaca, lo que compromete la eficacia del tratamiento. No se ha determinado una dosis máxima segura para el consumo humano de esta planta.
Otras plantas estudiadas para stimulant
Perfil completo: Ver todos los usos y evidencia de Yoco →